Teaser Image JMCP Cover Image Teaser Text The first biosimilar product filgrastim-sndz was approved by the FDA in 2015, but real-world evaluations of its uptake and cost in nationally representative populations are limited. Tags (Topics): Real World Evidence & Research URL https://www.jmcp.org/doi/abs/10.18553/jmcp.2021.27.5.660 Primary Taxonomy Tag Biosimilars
